Skip to content
healthcare.dev
Get a free key

Bupropion Hydrochloride

NDC 70518-2022, Bupropion Hydrochloride, tablet, extended release, from REMEDYREPACK INC..

Product NDC
70518-2022
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090693
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2022 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
70518-2022-27051820220290 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2022-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/740534d3-59b5-4938-8e38-16275a14438c

Use it

Look up 70518-2022 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-2022 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-2022. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.